A Randomised, Double Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability and to Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures.

Trial Profile

A Randomised, Double Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability and to Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 12 Aug 2014

At a glance

  • Drugs Zonisamide (Primary) ; Antiepileptic drugs
  • Indications Complex partial epilepsy
  • Focus Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 05 Feb 2013 Primary endpoint amended as reported by ClinicalTrials.gov record.
    • 13 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top